Evaluating the transferability of VMAT plans between dosimetrically matched Varian Clinac iX units for brain and head and neck cancer patients using an end-to-end test
- 11 February 2026
- journal article
- research article
- Published by Springer Nature in The European Physical Journal Special Topics
- Vol. 235 (4) , 1341-1349
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- End-to-End patient-specific VMAT quality assurance for common Head-and-Neck cancers using RANDO anthropomorphic phantom with OSLDRadiation Physics and Chemistry, 2025
- Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistencyRadiotherapy and Oncology, 2021
- AAPM Task Group 329: Reference dose specification for dose calculations: Dose‐to‐water or dose‐to‐muscle?Medical Physics, 2019
- IAEA methodology for on-site end-to-end IMRT/VMAT audits: an international pilot studyActa Oncologica, 2019
- Multi-institutional evaluation using the end-to-end test for implementation of dynamic techniques of radiation therapy in ThailandReports of Practical Oncology and Radiotherapy, 2019
- Validation of the Acuros XB dose calculation algorithm versus Monte Carlo for clinical treatment plansMedical Physics, 2018
- Tolerance limits and methodologies forIMRTmeasurement‐based verificationQA:Recommendations ofAAPMTask Group No. 218Medical Physics, 2018
- Accuracy of dose calculation algorithms for virtual heterogeneous phantoms and intensity-modulated radiation therapy in the head and neckRadiological Physics and Technology, 2015
- Potential advantages of volumetric arc therapy in head and neck cancerHead & Neck, 2014
- A beam-matching concept for medical linear acceleratorsActa Oncologica, 2009